Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer

Background: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30–50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sensitivity and specificity for early det...

Full description

Bibliographic Details
Main Authors: Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma Ivansson, Marta Lomnytska, Maria Lycke, Tomas Axelsson, Ulrika Liljedahl, Jessica Nordlund, Per-Henrik Edqvist, Tobias Sjöblom, Mathias Uhlén, Karin Stålberg, Karin Sundfeldt, Mikael Åberg, Stefan Enroth
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
ovarian cancer
protein biomarkers
early detection
Online Access:https://www.mdpi.com/2072-6694/14/7/1757

Internet

https://www.mdpi.com/2072-6694/14/7/1757

Similar Items